Measurement of matrix metalloproteinase activities in the medium of cultured synoviocytes using zymography.

Measurement of matrix metalloproteinase activities in the medium of cultured synoviocytes using zymography.

Dades bibliogràfiques
Autors principals:	Troeberg, L, Nagase, H
Format:	Journal article
Idioma:	English
Publicat:	2003

Ítems similars

Zymography of metalloproteinases.
per: Troeberg, L, et al.
Publicat: (2004)

Evaluation of matrix metalloproteinase and cysteine cathepsin activity in dentin hybrid layer by gelatin zymography
per: Sekar Mahalaxmi, et al.
Publicat: (2016-01-01)

Monitoring metalloproteinase activity using synthetic fluorogenic substrates.
per: Troeberg, L, et al.
Publicat: (2004)

Inhibitory effects of zinc hyaluronate on synoviocyte growth and matrix metalloproteinase-9 activity
per: Seiji Saito, et al.
Publicat: (2009-11-01)

Matrix metalloproteinases in cancer.
per: Itoh, Y, et al.
Publicat: (2002)

Localizing matrix metalloproteinase activities in the pericellular environment.
per: Murphy, G, et al.
Publicat: (2011)

Zymography for Picogram Detection of Lipase and Esterase Activities
per: Andre Mong Jie Ng, et al.
Publicat: (2021-03-01)

Endolysin Expression, Purification and Activity Determination by Zymography
per: Alexander Westbye, et al.
Publicat: (2014-08-01)

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
per: Visse, R, et al.
Publicat: (2003)

Progress in matrix metalloproteinase research.
per: Murphy, G, et al.
Publicat: (2008)

A personal journey with matrix metalloproteinases
per: Nagase, H
Publicat: (2016)

The role of matrix metalloproteinases in rheumatoid tendon disease.
per: Jain, A, et al.
Publicat: (2002)

Zymography: developing of the enzyme soil activity visualization method
per: M. V. Timofeeva, et al.
Publicat: (2023-01-01)

Structural requirements for collagenolytic activity of matrix metalloproteinase 1 (MMP-1)
per: Chung, L, et al.
Publicat: (2000)

Structure and function of matrix metalloproteinases and TIMPs.
per: Nagase, H, et al.
Publicat: (2006)

Proteases involved in cartilage matrix degradation in osteoarthritis.
per: Troeberg, L, et al.
Publicat: (2012)

Quantitation of the active alpha-2-macroglobulin by trypsin protease zymography
per: Gligorijević Nikola, et al.
Publicat: (2019-01-01)

In vivo imaging of matrix metalloproteinase 12 and matrix metalloproteinase 13 activities in the mouse model of collagen-induced arthritis.
per: Lim, N, et al.
Publicat: (2014)

Investigation of Punicic Acid Effects on Matrix Metalloproteinase Genes Expression in Bovine Fibroblast like-Synoviocytes as a Model of Osteoarthritis
per: Taherian, et al.
Publicat: (2018-09-01)

Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
per: Lauer-Fields, J, et al.
Publicat: (2001)

Kinetic analysis of matrix metalloproteinase triple-helicase activity using fluorogenic substrates
per: Sritharan, T, et al.
Publicat: (2001)

Engineered tissue inhibitor of metalloproteinases-3 variants resistant to endocytosis have prolonged chondroprotective activity
per: Doherty, C, et al.
Publicat: (2016)

Development of a solid-phase assay for analysis of matrix metalloproteinase activity.
per: Lauer-Fields, J, et al.
Publicat: (2004)

Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis.
per: Miller, M, et al.
Publicat: (2009)

E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).
per: Troeberg, L, et al.
Publicat: (2002)

Matrix metalloproteinases and their inhibitors in human vitreous.
per: De La Paz, MA, et al.
Publicat: (1998)

Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.
per: Itoh, Y, et al.
Publicat: (1995)

Ex vivo Follicle Rupture and in situ Zymography in Drosophila
per: Elizabeth Knapp, et al.
Publicat: (2018-05-01)

Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases.
per: Ogata, Y, et al.
Publicat: (1995)

Selective hydrolysis of triple-helical peptides by matrix metalloproteinases
per: Lauer-Fields, J, et al.
Publicat: (2000)

Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.
per: Minond, D, et al.
Publicat: (2004)

Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase.
per: Itoh, Y, et al.
Publicat: (1995)

Importance of matrix metalloproteinases in human trophoblast invasion.
per: Bischof, P, et al.
Publicat: (1995)

Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors.
per: Wei, S, et al.
Publicat: (2003)

Gelatin Zymography of Major Proteases in Exosomes of Leishmania major Promastigotes
per: Akram Azambakhtiar, et al.
Publicat: (2023-11-01)

Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network.
per: Kang, T, et al.
Publicat: (2002)

Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis.
per: Jain, A, et al.
Publicat: (2001)

Effect of serum-containing and serum-free culture medium-mediated activation of matrix metalloproteinases on embryonic developmental competence
per: Sang Hwan Kim, et al.
Publicat: (2019-12-01)

Connective tissue remodeling: cross-talk between endothelins and matrix metalloproteinases.
per: Abraham, D, et al.
Publicat: (2005)

Novel Ex Vivo Zymography Approach for Assessment of Protease Activity in Tissues with Activatable Antibodies
per: Bruce Howng, et al.
Publicat: (2021-09-01)